×

Pfizer-Allergan: 'This is a defect of US tax system'

6:32 PM ET Mon, 23 Nov 2015

Outcry about tax inversions have been a long-standing issue, explains Raghuram Selvaraju, managing director of equity research for healthcare at Rodman & Renshaw.